X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $87,841.04 -1.02%
Ethereum $2,980.22 -0.33%
BNB $856.62 -1.14%
Optimism $0.27 +1.28%
Arbitrum $0.19 -1.17%
Solana $124.90 -1.15%
Polygon $0.22 +2.77%
Cosmos $1.95 -0.74%
Avalanche $12.34 -1.64%

Bitcoin $87,841.04 -1.02%
Ethereum $2,980.22 -0.33%
BNB $856.62 -1.14%
Optimism $0.27 +1.28%
Arbitrum $0.19 -1.17%
Solana $124.90 -1.15%
Polygon $0.22 +2.77%
Cosmos $1.95 -0.74%
Avalanche $12.34 -1.64%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed